CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-18 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-08-18 | Tan Aik Na Director | Grant or award · Share Option (right to buy) | +21,000 | 21,000 | ||
| 2020-08-18 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-07-02 | BOLNO PAUL President and CEO | Sale | −4,509 | $10.82 | $49K | 315,249 |
| 2020-07-02 | BOLNO PAUL President and CEO | Sale | −43,068 | $10.26 | $442K | 272,181 |
| 2020-07-02 | BOLNO PAUL President and CEO | Exercise or conversion | +100,000 | $2.48 | $248K | 372,181 |
| 2020-07-02 | BOLNO PAUL President and CEO | Sale | −4,079 | $10.91 | $45K | 368,102 |
| 2020-07-02 | BOLNO PAUL President and CEO | Sale | −95,921 | $10.27 | $985K | 272,181 |
| 2020-07-02 | BOLNO PAUL President and CEO | Exercise or conversion · Share Option (right to buy) | −100,000 | 222,778 | ||
| 2020-03-03 | Vargeese Chandra Senior VP, Drug Discovery | Grant or award · Share Option (right to buy) | +36,000 | 36,000 | ||
| 2020-03-03 | Gaiero David G Interim CFO | Grant or award · Share Option (right to buy) | +18,000 | 18,000 | ||
| 2020-03-03 | BOLNO PAUL President and CEO | Grant or award · Share Option (right to buy) | +63,000 | 63,000 | ||
| 2020-03-03 | Francis Chris | Grant or award · Share Option (right to buy) | +36,000 | 36,000 | ||
| 2020-03-03 | Panzara Michael A. Chief Medical Officer | Grant or award · Share Option (right to buy) | +36,000 | 36,000 | ||
| 2020-02-18 | Panzara Michael A. Chief Medical Officer | Sale | −2,981 | $7.85 | $23K | 39,349 |
| 2020-02-18 | BOLNO PAUL President and CEO | Sale | −11,451 | $7.85 | $90K | 319,758 |
| 2020-02-18 | Francis Chris | Sale | −2,708 | $7.85 | $21K | 31,160 |
| 2020-02-18 | Vargeese Chandra Senior VP, Drug Discovery | Sale | −3,188 | $7.85 | $25K | 37,057 |
| 2020-02-03 | Gaiero David G Interim CFO | Sale | −651 | $7.00 | $5K | 6,392 |
| 2019-12-03 | Vargeese Chandra Senior VP, Drug Discovery | Exercise or conversion | +6,000 | $2.48 | $15K | 46,245 |
Page 17 of 22 · 433 trades